Does Mounjaro Help With Insulin Resistance?

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist. Both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are hormones involved in regulating blood sugar — they stimulate insulin release in response to eating and play a role in how cells respond to that insulin. By activating both receptors, tirzepatide works on two overlapping parts of this system simultaneously.

Insulin resistance and weight

Insulin resistance — where the body's cells become less responsive to insulin — is closely associated with excess body weight, particularly around the abdomen. Weight reduction is one of the most well-established ways to improve insulin sensitivity, and because tirzepatide is associated with significant weight change in many people who take it, some improvement in insulin resistance markers is commonly reported in those prescribed it. It is important to note that individual responses vary considerably, and your prescriber is best placed to monitor any changes in your blood sugar or insulin markers.

Other conditions people ask about

People prescribed Mounjaro often ask whether it might also help with a range of related or overlapping conditions. Some of these questions reflect the wide-reaching effects that metabolic health and inflammation can have on the body:

• Inflammation: Chronic low-grade inflammation is linked to insulin resistance and metabolic dysfunction. Some research suggests GLP-1 receptor agonists may have anti-inflammatory effects, though this remains an active area of study and is not an established clinical indication.
• Lipedema: Lipedema is a condition involving abnormal fat distribution, distinct from general obesity. Whether GLP-1 medicines affect lipedema specifically is not well established; any questions about this should go directly to your prescriber or doctor.
• Menopause: Hormonal changes during menopause can affect insulin sensitivity and weight distribution. Some people find that managing weight during this time becomes harder; how tirzepatide interacts with menopause-related changes is individual, and your healthcare professional is the right person to advise you.
• Neuropathy and arthritis: Both conditions can be associated with inflammation and metabolic factors. There is no established clinical indication for Mounjaro in either, though people living with both conditions and prescribed tirzepatide for weight management sometimes ask about broader effects. Always raise these questions with your prescriber.
• Anxiety: Some people report changes in mood or anxiety on GLP-1 medicines; this is a topic under ongoing research. Mental health changes are a special-care topic — if you notice significant mood or anxiety shifts, contact your healthcare professional promptly.

For a broader look at how this medicine works in the body, the page on how Mounjaro works covers the mechanism in more detail. If you have questions specifically about PCOS and metabolic health, see the related page on Mounjaro and PCOS. You may also find it useful to read about how quickly Mounjaro typically takes effect.

If you are prescribed Mounjaro partly because of insulin resistance or related metabolic concerns, keeping a clear record of how you feel over time can be genuinely valuable — both for your own understanding and for conversations with your prescriber.

GLP Trackr's daily check-in lets you log energy levels, mood, and general wellbeing each morning in under a minute. Over weeks and months, these logs build into a picture of how your experience is changing — information that is easy to forget but meaningful to bring to an appointment. The app's insights and analytics surface patterns from your own data, including how weight, food intake, and daily habits correlate over time, which can help you and your prescriber have more informed conversations about your progress.

You can also use the doctor report feature to generate a clean summary of your journey — doses, weight trend, side effects, and wellbeing — ready to share at your next clinical appointment.

GLP Trackr is an informational tracking tool, not a clinical service. Any questions about your insulin markers, blood test results, or whether your metabolic health is improving should always go to your prescriber or doctor — they have your full medical history and are best placed to interpret the numbers. If you notice anything that concerns you, including significant mood changes or symptoms that feel new or severe, contact your healthcare professional promptly. You can also read about other health questions people have about Mounjaro for factual, neutral information.

Capture your energy, mood, and weight trends in one place as your journey progresses. GLP Trackr is free to start on the App Store and Google Play — your first 7 days are on us.